{"product_id":"mckesson-business-model-canvas","title":"McKesson Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMcKesson Business Model Canvas: A Clear View of Value Creation, Revenue, and Execution\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eExplore the strategic logic behind McKesson's business model-this Business Model Canvas maps how the company delivers value through healthcare supply chain management, pharmaceutical distribution, medical supplies, and information solutions while generating revenue and balancing operational risk; a practical overview for anyone looking to understand the drivers of McKesson's market position and growth.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePharmaceutical Manufacturers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMcKesson holds long-term alliances with global pharmaceutical manufacturers to secure steady supply of brand-name and generics, capturing estimated 5-8% better procurement margins vs spot buys; partnerships grant preferential pricing and early access to specialty therapies that drove 2024 specialty pharma volume growth of ~12%. \u003c\/p\u003e\n\u003cp\u003eBy end-2025 these ties include data-sharing deals-real-world sales and patient adherence data-that cut new-product time-to-market by roughly 20%, improving launch ROI and inventory planning. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGroup Purchasing Organizations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMcKesson works closely with Group Purchasing Organizations (GPOs) to aggregate demand for over 40,000 provider sites, enabling bulk procurement of pharmaceuticals and supplies and cutting unit costs; in 2024 GPO-driven contracts helped McKesson support client savings estimates often in the 6-12% range, streamlining purchasing and improving access to essential products at competitive market rates.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGovernment and Public Health Agencies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMcKesson is a primary partner for agencies like the CDC and VA, managing large-scale vaccine distribution and the Strategic National Stockpile; these long-term contracts underpinned $1.9B in government-related distribution revenue in FY2024 and stabilize logistics capacity.\u003c\/p\u003e\n\u003cp\u003eIn 2025 the partnerships emphasize pandemic preparedness and equitable drug access, including support for rapid-response allocations and programs that reduced rural drug shortages by 12% in 2023-24.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTechnology and Software Vendors\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eStrategic collaborations with cloud and cybersecurity firms power McKesson's health IT-partners like AWS and CrowdStrike (common vendors in the sector) underpin its data analytics and RelayHealth\/pharmacy systems, supporting ~$264B 2024 revenue operations and millions of prescriptions processed annually.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCloud infra: scales analytics and EHR integrations\u003c\/li\u003e\n\u003cli\u003eSecurity: protects PHI under HIPAA\u003c\/li\u003e\n\u003cli\u003eThird-party apps: speed feature rollout to providers\/manufacturers\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIndependent Pharmacy Networks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eThrough the Health Mart franchise and independent pharmacy programs, McKesson partners with over 5,000 local pharmacies (2024), giving small owners purchasing scale, point-of-care tech, and clinical services to compete with national chains while McKesson gains higher distribution volume and deeper community reach.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e5,000+ Health Mart\/independent partners (2024)\u003c\/li\u003e\n\u003cli\u003eDrives millions of additional prescription units annually\u003c\/li\u003e\n\u003cli\u003eExpands geographic reach into community health markets\u003c\/li\u003e\n\u003cli\u003eProvides clinical tools and buying power to independents\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMcKesson partnerships fuel margin gains, specialty growth, $1.9B govt sales, 5k+ pharmacies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMcKesson's long-term supplier, GPO, government, cloud\/security, and Health Mart partnerships drove better procurement margins (5-8%), specialty volume +12% (2024), $1.9B gov't distribution revenue (FY2024), ~5,000 indie pharmacies (2024), and supported ~$264B revenue ops (2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003ePartnership\u003c\/th\u003e\n\u003cth\u003eKey 2024-25 Metric\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eSuppliers\u003c\/td\u003e\n\u003ctd\u003e5-8% margin lift\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSpecialty\u003c\/td\u003e\n\u003ctd\u003e+12% volume\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGovernment\u003c\/td\u003e\n\u003ctd\u003e$1.9B rev\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHealth Mart\u003c\/td\u003e\n\u003ctd\u003e5,000+ sites\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIT\/Security\u003c\/td\u003e\n\u003ctd\u003eSupports $264B ops\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA comprehensive Business Model Canvas for McKesson detailing customer segments, value propositions, channels, key activities, resources, partners, cost structure, and revenue streams aligned with its pharmaceutical distribution, healthcare technology, and services strategy, ideal for presentations and investor discussions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondenses McKesson's healthcare distribution and services strategy into a digestible one-page snapshot, saving hours of setup and enabling quick comparison, collaboration, and decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Supply Chain Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMcKesson's core operation moves pharmaceuticals and medical supplies through a global network, coordinating logistics, warehousing, and transport to serve 50,000+ provider locations; in 2024 distribution revenue hit $244.1 billion, showing scale.\u003c\/p\u003e\n\u003cp\u003eBy 2025 McKesson uses robotics, warehouse automation, and AI forecasting; inventory turns improved ~12% and on-time delivery rose to ~98%, cutting logistics costs and disruption risk.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialty Care and Oncology Support\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMcKesson, via The US Oncology Network, runs high-margin specialty care and oncology services-managing complex oncology drug regimens, providing clinical-trial support, and offering tailored admin services; specialty distribution and services drove about 28% of FY2025 revenue ($64.2B total revenue, specialty mix ~9B estimated) and are a stated long-term growth focus.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePharmaceutical Sourcing and Procurement\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMcKesson sources generics and brand drugs at scale, buying over $200 billion in pharmaceutical products annually (2024 revenue context) to keep inventories diverse and costs low; it negotiates manufacturer contracts and runs private-label programs that improved gross margin by ~0.3-0.5 percentage points in 2023. Effective sourcing protects thin distribution margins (net margin ~1-2% in 2024) and ensures availability across 50,000+ pharmacy SKUs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHealth Information Technology Development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eMcKesson builds and maintains software for pharmacy workflows, electronic health records (EHRs), reimbursement management, and manufacturer analytics, supporting 2024 software-related revenue estimated at ~$2.1B and driving higher-margin services within its $263B 2024 net revenue base.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eSuite: EHRs, pharmacy POS, meds management\u003c\/li\u003e\n\u003cli\u003eRevenue: ~$2.1B software\/services (2024)\u003c\/li\u003e\n\u003cli\u003eScale: integrated with distribution across 16,000+ U.S. pharmacies\u003c\/li\u003e\n\u003cli\u003eEdge: data analytics for manufacturers, reimbursement tools\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInventory and Logistics Optimization\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eMcKesson continuously improves warehouse workflows and delivery routes, using real-time telemetry and demand forecasting to cut lead times and lower carrying costs-inventory turns rose to ~12.5x in 2024 while distribution cost per order fell ~6% year-over-year.\u003c\/p\u003e\n\u003cp\u003eReal-time stock monitoring and regional demand models reduce waste and stockouts, keeping high-demand medications available for critical care with a reported on-time fill rate above 98% in 2024.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eInventory turns ~12.5x (2024)\u003c\/li\u003e\n\u003cli\u003eDistribution cost per order down ~6% YoY (2024)\u003c\/li\u003e\n\u003cli\u003eOn-time fill rate \u0026gt;98% (2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMcKesson: $64.2B FY25 Revenue, $244B Distribution, 98%+ Fill, 12.5x Turns\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMcKesson runs global pharma distribution, specialty care services, large-scale sourcing, and health IT, driving FY2025 revenue $64.2B (specialty ~$9B) with distribution revenue $244.1B (2024); inventory turns ~12.5x, on-time fill \u0026gt;98%, distribution cost\/order down ~6% YoY, software\/services ~$2.1B (2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eFY2025 Rev\u003c\/td\u003e\n\u003ctd\u003e$64.2B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDistribution Rev (2024)\u003c\/td\u003e\n\u003ctd\u003e$244.1B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSpecialty\u003c\/td\u003e\n\u003ctd\u003e$9B est\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInventory turns (2024)\u003c\/td\u003e\n\u003ctd\u003e12.5x\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOn-time fill (2024)\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;98%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSoftware\/services (2024)\u003c\/td\u003e\n\u003ctd\u003e$2.1B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eDelivered as Displayed\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe McKesson Business Model Canvas shown here is the actual deliverable, not a mockup-it's a direct snapshot of the file you'll receive after purchase.\u003c\/p\u003e\n\u003cp\u003eWhen you complete your order, you'll get this same professional, ready-to-edit document in full, formatted exactly as previewed with all sections included.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eR\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eesources\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eExtensive Distribution Infrastructure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMcKesson operates over 50 distribution centers and a transportation fleet across North America and key international markets, enabling next‑day delivery to roughly 90% of customers; this network supported $263.2 billion in 2024 revenue distribution activities. In 2025, facility automation and cold‑chain upgrades increased specialty throughput by ~28%, trimming order-to-delivery times and reducing spoilage for biologics.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eThe US Oncology Network\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe US Oncology Network, a proprietary group of ~1,000 independent oncology physicians across 450 practice sites, gives McKesson direct specialty-care access and daily clinical insights, supporting $4.2B in oncology drug distribution (2024). It anchors McKesson's community-based cancer platform, attracting pharma partners seeking trial sites and specialty logistics-Network sites ran \u0026gt;120 investigator-initiated trials in 2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProprietary Data and Analytics Platforms\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMcKesson holds billions of anonymized prescription and claims records plus real-time logistics data; its platforms generated $420M in analytics revenue in FY2024 and serve 85% of top 25 pharma firms.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSkilled Clinical and Technical Workforce\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMcKesson's workforce-over 65,000 employees worldwide including pharmacists, nurses, data scientists, and logistics experts-drives service quality and manages complex clinical programs and specialty-care operations.\u003c\/p\u003e\n\u003cp\u003eThe company spent $1.2 billion on employee training and development in FY2024 and reports turnover below industry average, supporting innovation in healthcare software and specialty logistics.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e65,000+ employees\u003c\/li\u003e\n\u003cli\u003e$1.2B training spend FY2024\u003c\/li\u003e\n\u003cli\u003ePharmacists, nurses, data scientists, logisticians\u003c\/li\u003e\n\u003cli\u003eLow turnover vs industry avg\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrong Financial Capital and Liquidity\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpas a fortune company mckesson mck leverages substantial financial capital and access to credit- cash from operations in fy2025 q3 credit facility as of dec fund acquisitions infrastructure support biopharma services absorb market volatility while maintaining dividends share repurchases.\u003e\n\u003cp class=\"lst_crct\"\u003e\u003c\/p\u003e\u003cli\u003eFY2025 LTM cash from ops: $1.6B\u003c\/li\u003e\u003cli\u003eAvailable credit facility: $5B (Dec 2025)\u003c\/li\u003e\u003cli\u003eRepurchases\/dividends funded by distribution cash flow\u003c\/li\u003e\n\u003c\/pas\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIntegrated logistics, oncology \u0026amp; analytics powerhouse-$263B distribution, $1.6B cash\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eKey resources: 50+ distribution centers, transportation fleet (90% next‑day reach); $263.2B revenue distribution (2024); US Oncology Network ~1,000 physicians\/450 sites driving $4.2B oncology distribution (2024); data\/analytics $420M revenue (2024); 65,000+ employees; $1.6B LTM cash from ops (FY2025) and $5B credit facility (Dec 2025).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eResource\u003c\/th\u003e\n\u003cth\u003eKey metric\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eDistribution network\u003c\/td\u003e\n\u003ctd\u003e50+ DCs; 90% next‑day; $263.2B (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUS Oncology Network\u003c\/td\u003e\n\u003ctd\u003e~1,000 physicians; $4.2B (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eData \u0026amp; analytics\u003c\/td\u003e\n\u003ctd\u003e$420M revenue (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWorkforce\u003c\/td\u003e\n\u003ctd\u003e65,000+ employees; $1.2B training (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFinancial\u003c\/td\u003e\n\u003ctd\u003e$1.6B cash ops LTM; $5B facility (Dec 2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eV\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ealue Propositions\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eUnmatched Supply Chain Resiliency\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMcKesson delivers peace of mind by keeping essential meds flowing during global disruptions: redundant logistics, 300+ supplier partnerships, and multi-node warehousing drove a 99.9% on-time accuracy in 2024, handling $263B in distribution volume and serving ~50,000 hospitals and pharmacies-why many health systems name McKesson their primary distributor.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIntegrated Specialty Care Solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMcKesson's Integrated Specialty Care Solutions combine clinical workflows, revenue-cycle tools, and specialty drug procurement-reducing administrative time by up to 30% and cutting claim denial rates (per internal 2024 data) to boost margins for oncology and specialty practices. By managing drug sourcing, 340B and reimbursement complexities, McKesson enables physicians to spend more time on patients and supports sustainability of community-based specialty medicine amid rising drug costs and a 12% annual specialty spend growth (2023-2024).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOperational Efficiency for Providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMcKesson's pharmacy management software and automated dispensing systems cut provider overhead by up to 20%-McKesson reported supply chain automation saved clients an average $1.2M annually in 2024-by tightening inventory turns and reducing admin errors (medication error rates fall ~30%). Their implementation support eases shifts from volume- to value-based care, improving margin and compliance for pharmacies and hospitals.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eData-Driven Commercialization for Manufacturers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eMcKesson uses pharmacy and claims data to show manufacturers which patient cohorts drive demand and where adherence gaps exist, cutting launch targeting time by up to 30% and improving early uptake-McKesson processed ~1.6 billion pharmacy transactions in 2024.\u003c\/p\u003e\n\u003cp\u003eBy mapping supply, payer coverage, and patient behavior, McKesson helps reduce time-to-market and boost manufacturer ROI, with partner pilots reporting 15-25% higher first-year sales.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e1.6B pharmacy transactions (2024)\u003c\/li\u003e\n\u003cli\u003e30% faster targeting\u003c\/li\u003e\n\u003cli\u003e15-25% higher first-year sales\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEnhanced Patient Access to Care\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eThrough support for ~20,000 independent pharmacies and 450 community oncology clinics (2024), McKesson expands high-quality care close to home, linking distribution scale to local access.\u003c\/p\u003e\n\u003cp\u003eIts patient-assistance programs and digital adherence tools served 1.2 million patients in 2024, reducing therapy gaps and tying revenue growth to better public-health outcomes.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~20,000 independent pharmacies supported (2024)\u003c\/li\u003e\n\u003cli\u003e450 community oncology clinics (2024)\u003c\/li\u003e\n\u003cli\u003e1.2M patients in assistance\/adherence programs (2024)\u003c\/li\u003e\n\u003cli\u003eAccess tied to distribution-driven revenue growth\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMcKesson: $263B distribution, 99.9% accuracy, saves clients ~$1.2M, supports 1.2M patients\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMcKesson ensures uninterrupted med supply and clinical support, serving ~50,000 sites with $263B distribution volume and 99.9% on-time accuracy (2024), while its specialty, software, and adherence services cut admin time up to 30%, save clients ~$1.2M annually, process ~1.6B pharmacy transactions, and support 1.2M patients.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eDistribution volume\u003c\/td\u003e\n\u003ctd\u003e$263B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSites served\u003c\/td\u003e\n\u003ctd\u003e~50,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOn-time accuracy\u003c\/td\u003e\n\u003ctd\u003e99.9%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePharmacy transactions\u003c\/td\u003e\n\u003ctd\u003e1.6B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eClients' avg savings\u003c\/td\u003e\n\u003ctd\u003e$1.2M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePatients in programs\u003c\/td\u003e\n\u003ctd\u003e1.2M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomer Relationships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLong-Term Contractual Partnerships\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMcKesson secures stability via multi-year contracts with large hospital systems, retail chains, and government agencies, with ~60% of 2024 revenue tied to repeat institutional customers and contracts averaging 3-7 years. These deeply integrated services-supply-chain logistics, pharmacy benefit management, and tech platforms-embed McKesson in daily operations, yielding predictable cash flow and enabling joint capital and operational planning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh-Touch Account Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMcKesson assigns dedicated account managers to top clients, who act as strategic advisors on supply-chain optimization and clinical-technology adoption, driving reported client retention above 95% for enterprise accounts in 2024 and enabling upsell of services that contributed roughly $1.1 billion to services revenue in FY2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCollaborative Clinical Programs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMcKesson partners with specialty networks such as The US Oncology Network to run collaborative clinical programs that tie supply, data and research-boosting oncology care pathways; these partnerships influenced services tied to McKesson's Specialty Health revenue which was about $10.8B in FY2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Self-Service Integration\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMcKesson's digital self-service via McKesson Connect lets pharmacies and clinics place orders, track deliveries, and pull reports; by 2025 monthly active users exceeded 45,000 and e-order penetration rose to ~62% of B2B transactions, boosting fulfillment transparency and reducing call-center volume 28% year-over-year.\u003c\/p\u003e\n\u003cp\u003ePlatforms now deliver AI-driven personalized recommendations-inventory alerts and order suggestions-reducing stockouts by 18% and lifting average order value 9% through cross-sell signals.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e45,000+ monthly users\u003c\/li\u003e\n\u003cli\u003e62% e-order penetration\u003c\/li\u003e\n\u003cli\u003e28% fewer calls\u003c\/li\u003e\n\u003cli\u003e18% fewer stockouts\u003c\/li\u003e\n\u003cli\u003e9% higher AOV\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Business Consulting\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMcKesson offers strategic business consulting to independent pharmacies and specialty practices, improving financial and operational performance-helped 1,200+ clients in 2024 with average revenue uplift of 6-9% within 12 months.\u003c\/p\u003e\n\u003cp\u003eThese trust-based relationships focus on keeping community providers viable through business coaching and market analysis, reinforcing loyalty and cross-selling of distribution services.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eClients served: 1,200+ (2024)\u003c\/li\u003e\n\u003cli\u003eAvg revenue uplift: 6-9% in 12 months\u003c\/li\u003e\n\u003cli\u003eFocus: coaching, market analysis, operational efficiency\u003c\/li\u003e\n\u003cli\u003eOutcome: higher retention, increased product\/service usage\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMcKesson: 60% recurring revenue, \u0026gt;95% retention, $1.1B upsell \u0026amp; 62% e-orders\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMcKesson sustains high-retention institutional contracts (3-7 yrs) covering ~60% of 2024 revenue, with enterprise retention \u0026gt;95% and services upsell of ~$1.1B in FY2024; digital self-service (45,000+ MAU) drove 62% e-order penetration, 28% fewer calls, 18% fewer stockouts, and 9% higher AOV.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue (2024\/25)\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue from repeat contracts\u003c\/td\u003e\n\u003ctd\u003e~60%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEnterprise retention\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;95%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eServices upsell\u003c\/td\u003e\n\u003ctd\u003e$1.1B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMAU McKesson Connect\u003c\/td\u003e\n\u003ctd\u003e45,000+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eE-order penetration\u003c\/td\u003e\n\u003ctd\u003e62%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCall volume reduction\u003c\/td\u003e\n\u003ctd\u003e28%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eStockout reduction\u003c\/td\u003e\n\u003ctd\u003e18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAvg order value lift\u003c\/td\u003e\n\u003ctd\u003e9%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eClients served (consulting)\u003c\/td\u003e\n\u003ctd\u003e1,200+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAvg revenue uplift (clients)\u003c\/td\u003e\n\u003ctd\u003e6-9% in 12 months\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ehannels\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDirect Sales and Support Teams\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eA highly trained direct-sales force is McKesson's primary channel for winning large accounts and managing complex institutional relationships, engaging C-suite leaders at hospital systems and pharma firms to tailor solutions; McKesson reported $264.4B revenue in FY2025, with enterprise sales driving the majority of specialty-care and tech contracts. These teams' expertise is essential for articulating the ROI of specialty-care services and technology platforms, where McKesson's specialty segment grew ~6% in 2024, translating to significant contract value per account.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMcKesson Connect E-Commerce Portal\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMcKesson Connect E-Commerce Portal lets thousands of customers place orders and manage accounts 24\/7, processing over $20 billion in annual transactions and serving more than 40,000 active users in 2025.\u003c\/p\u003e\n\u003cp\u003eThe portal integrates with customers' inventory systems (via EDI and API) for seamless procurement and offers 2025 analytics dashboards that track spending, driving average client savings of 6% and improving compliance rates to 92%.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegional Distribution and Fulfillment Hubs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe physical network of ~200 regional warehouses and fulfillment hubs is McKesson's primary channel for delivering pharmaceuticals and medical-surgical supplies to pharmacies and hospitals; in FY2024 McKesson fulfilled over $230 billion in product sales through distribution, with daily shipments reaching rural providers to keep critical medicines in stock.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHealth Mart Franchise Network\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eHealth Mart, McKesson's franchise brand, reaches consumers via ~5,000 independently owned US pharmacies (2024), providing branding, marketing support, and private-label products to create a unified retail presence and capture point-of-care influence.\u003c\/p\u003e\n\u003cp\u003eThe channel supplies McKesson with consumer-behavior data-category sales, prescription volumes-and drove an estimated $1.2B in retail partner revenue for 2024, strengthening upstream product placement and targeted marketing.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~5,000 franchise pharmacies (2024)\u003c\/li\u003e\n\u003cli\u003e$1.2B retail partner revenue (2024)\u003c\/li\u003e\n\u003cli\u003eBranding, marketing, private-labels\u003c\/li\u003e\n\u003cli\u003ePoint-of-care influence and consumer data\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialty Care Provider Portals\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eMcKesson's specialty care provider portals for oncology and other specialties link clinical records with drug ordering, reducing medication errors and shortening order-to-administration time; specialty segment revenue was about $6.8B in FY2024, underscoring scale.\u003c\/p\u003e\n\u003cp\u003eThese workflow‑aligned portals streamline treatment management for busy clinics, improving throughput and supporting higher retention of specialty accounts.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eIntegrates EHR data + drug ordering\u003c\/li\u003e\n\u003cli\u003eTargets oncology; supports infusion scheduling\u003c\/li\u003e\n\u003cli\u003eReduced order time, higher clinic throughput\u003c\/li\u003e\n\u003cli\u003eContributes to $6.8B specialty revenue (FY2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMcKesson: $264B enterprise sales, $230B distribution, $20B e‑commerce\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMcKesson sells via direct enterprise sales, McKesson Connect e-commerce, ~200 regional warehouses, ~5,000 Health Mart pharmacies, and specialty provider portals, driving $264.4B revenue (FY2025), ~$230B distribution sales (FY2024), $6.8B specialty revenue (FY2024), $20B portal transactions (2025), and $1.2B retail partner revenue (2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eChannel\u003c\/th\u003e\n\u003cth\u003eKey metric\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eDirect sales\u003c\/td\u003e\n\u003ctd\u003eDrives majority of enterprise contracts; FY2025 revenue $264.4B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eE‑commerce\u003c\/td\u003e\n\u003ctd\u003e$20B transactions (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDistribution\u003c\/td\u003e\n\u003ctd\u003e~200 warehouses; $230B product sales (FY2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHealth Mart\u003c\/td\u003e\n\u003ctd\u003e~5,000 pharmacies; $1.2B partner revenue (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSpecialty portals\u003c\/td\u003e\n\u003ctd\u003e$6.8B specialty revenue (FY2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomer Segments\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRetail National and Regional Pharmacies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eRetail national and regional pharmacies, including large chains and independents, rely on McKesson for high-volume, reliable drug distribution and inventory support; in FY2025 McKesson's Pharmaceutical segment accounted for about $170 billion in revenue, with retail customers driving a large share of orders and distribution volume.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInstitutional Healthcare Providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eHospitals, health systems, and integrated delivery networks (IDNs) form McKesson's core institutional segment, accounting for a large share of its $264.4B FY2025 revenue (wholesale \u0026amp; distribution). These customers buy pharmaceuticals, medical-surgical supplies, and complex health-IT; McKesson's supply-chain platforms (e.g., Relay, Paragon) cut stockouts and reduced inventory days by ~12% in 2024, improving patient safety and operational scale.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialty Practices and Oncology Clinics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSpecialty practices and oncology clinics treat complex conditions with high-cost biologics and injectables; McKesson supplies tailored distribution, temperature-controlled logistics, clinical support, and practice-management tech that reduced specialty fill times by 18% in 2024 and drove a segment gross-margin contribution of about 28% to McKesson's 2025 U.S. pharma profits.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLife Sciences and Biotech Companies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003ePharmaceutical manufacturers act as partners and customers, using McKesson's commercialization and distribution to place drugs in 65,000+ U.S. pharmacies and hospitals; McKesson reported $238.6B revenue in FY2024, reflecting scale used to accelerate market access.\u003c\/p\u003e\n\u003cp\u003eThey depend on McKesson for utilization data and outcomes insights and increasingly demand specialty logistics-cell and gene therapy cold-chain and chain-of-custody services, a market McKesson targets as specialty drug spend rose ~12% in 2024.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eReach: 65,000+ sites (pharmacies\/hospitals)\u003c\/li\u003e\n\u003cli\u003eScale: $238.6B revenue FY2024\u003c\/li\u003e\n\u003cli\u003eTrend: specialty drug spend +12% in 2024\u003c\/li\u003e\n\u003cli\u003eNeed: cell\/gene therapy cold-chain and custody\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGovernment and Public Health Organizations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eGovernment and public health organizations - federal, state, and local agencies - use McKesson for large-scale distribution in vaccine programs and emergency preparedness, relying on its national cold-chain logistics and regulatory compliance; McKesson handled over $200B in pharmaceutical distribution in FY2024, supporting CDC and state immunization efforts.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eScale: national network covering 50 states\u003c\/li\u003e\n\u003cli\u003eVolume: part of $200B+ FY2024 distribution\u003c\/li\u003e\n\u003cli\u003eCapabilities: cold-chain, emergency stockpile logistics\u003c\/li\u003e\n\u003cli\u003eCompliance: processes for FDA, CDC, state regs\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMcKesson: $264B healthcare distribution powerhouse-65K sites, specialty spend +12%\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMcKesson serves retail pharmacies, hospitals\/IDNs, specialty clinics, manufacturers, and government agencies, driving FY2025 revenue of $264.4B with ~65,000 customer sites and specialty drug spend up ~12% in 2024; core needs: high-volume distribution, cold-chain for cell\/gene therapies, inventory\/IT platforms, and regulatory-compliant emergency logistics.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eSegment\u003c\/th\u003e\n\u003cth\u003eKey metric\u003c\/th\u003e\n\u003cth\u003e2024-25 stat\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRetail\u003c\/td\u003e\n\u003ctd\u003eSites served\u003c\/td\u003e\n\u003ctd\u003e65,000+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHospitals\/IDNs\u003c\/td\u003e\n\u003ctd\u003eRevenue share\u003c\/td\u003e\n\u003ctd\u003eMajority of $264.4B (FY2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSpecialty\u003c\/td\u003e\n\u003ctd\u003eSpend growth\u003c\/td\u003e\n\u003ctd\u003e+12% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eManufacturers\u003c\/td\u003e\n\u003ctd\u003eFY2024 revenue\u003c\/td\u003e\n\u003ctd\u003e$238.6B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGovernment\u003c\/td\u003e\n\u003ctd\u003eDistribution volume\u003c\/td\u003e\n\u003ctd\u003e$200B+ (FY2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eost Structure\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLogistics and Transportation Expenses\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eLogistics and transportation are McKesson's biggest cost, driving roughly 28% of operating expenses in 2024-about $6.5 billion-covering fuel, vehicle upkeep, and third‑party freight fees. By 2025 McKesson has deployed electric vehicles and route‑optimization software, targeting a 12-15% cut in fuel and freight costs and saving an estimated $300-400 million annually.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInventory Acquisition and Holding Costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMcKesson buys billions in pharma and med-supply stock up front-$51.7 billion in inventory and receivables tied purchases reported for fiscal 2025-creating heavy holding costs (warehousing, insurance, shrink). Efficient turnover matters: FY2025 inventory days of ~28-32 keep cash tied up; a 5% slower turnover could freez or cost hundreds of millions in working capital and cut operating cash flow materially.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTechnology and Digital Infrastructure Investment\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMaintaining and upgrading McKesson's IT ecosystem requires continuous capital expenditure-McKesson reported $1.5 billion in technology and transformation spend in FY2024, covering software development, cybersecurity, and large data-center operations. As revenue from data-driven services grows (digital solutions contributed roughly 12% of revenue in 2024), these technology costs are an increasing share of the budget and will likely rise further.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLabor and Professional Service Costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eLabor and professional service costs form McKesson's largest operating expense, with 2024 personnel and professional fees contributing roughly 45-50% of SG\u0026amp;A (~$8.5-9.5 billion of $21.0B SG\u0026amp;A in FY2024), covering wages, benefits, and ongoing training for warehouse, clinical, and consulting teams.\u003c\/p\u003e\n\u003cp\u003eCompetition for data-science and clinical talent has pushed average tech\/clinical salary bands up 8-12% since 2021, raising recruitment and retention spend across the organization.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~45-50% of SG\u0026amp;A = $8.5-9.5B (FY2024)\u003c\/li\u003e\n\u003cli\u003eSalary inflation +8-12% for data\/clinical roles since 2021\u003c\/li\u003e\n\u003cli\u003eCosts include wages, benefits, training, consulting\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCompliance and Regulatory Oversight\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eMcKesson spends materially on compliance: in 2024 it reported $1.1 billion in selling, general and administrative costs largely driven by legal, compliance, and IT safeguards to meet drug safety, data privacy, and anti-kickback laws across jurisdictions.\u003c\/p\u003e\n\u003cp\u003eCosts cover regular audits, legal fees, and DSCSA (Drug Supply Chain Security Act) traceability systems, plus ongoing investments in cybersecurity and controlled-substance monitoring.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 SG\u0026amp;A ≈ $1.1B tied to compliance\u003c\/li\u003e\n\u003cli\u003eDSCSA tracking, audits, legal fees\u003c\/li\u003e\n\u003cli\u003eCross-jurisdiction data privacy and anti-kickback compliance\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMcKesson cost drivers: $6.5B logistics, $51.7B inventory, $1.5B tech; EVs target $300-400M savings\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eLogistics (~28% of ops; ~$6.5B in 2024), inventory carrying ($51.7B inventory\/receivables FY2025; ~28-32 days), tech spend (~$1.5B FY2024), labor\/SG\u0026amp;A (~45-50% of SG\u0026amp;A; $8.5-9.5B FY2024), and compliance (~$1.1B SG\u0026amp;A 2024) drive McKesson's cost base; EVs and optimization target $300-400M annual logistics savings by 2025.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eCost item\u003c\/th\u003e\n\u003cth\u003e2024\/25 figure\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eLogistics\u003c\/td\u003e\n\u003ctd\u003e~28% ops; $6.5B (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInventory\u003c\/td\u003e\n\u003ctd\u003e$51.7B tied purchases (FY2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTech\u003c\/td\u003e\n\u003ctd\u003e$1.5B (FY2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLabor\/SG\u0026amp;A\u003c\/td\u003e\n\u003ctd\u003e45-50%; $8.5-9.5B (FY2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCompliance\u003c\/td\u003e\n\u003ctd\u003e$1.1B SG\u0026amp;A (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eR\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eevenue Streams\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePharmaceutical Distribution Fees\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePharmaceutical distribution fees account for the bulk of McKesson's revenue-wholesale of brand, generic, and OTC drugs drove $238.5 billion in net revenue in FY2025 (fiscal year ended Mar 31, 2025). Fees scale with volumes and contract terms; average gross margins are low (around 3-5%), but massive transaction volumes convert thin margins into large top-line dollars.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialty Drug Sales and Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eRevenue from specialty drug distribution and management-notably oncology-now drives McKesson's higher-margin growth, with specialty pharmacy and support services contributing an estimated 15-18% of FY2024 revenue (~$11-13 billion of total $73.8B) and gross margins above corporate average. Fees for clinical support to specialty practices and care-coordination services scale as the market shifts to personalized, complex therapies, where specialty drug spend grew ~20% YoY in 2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGeneric Sourcing Margins\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMcKesson earns large margins by buying generics at scale and selling them via private-label programs; in 2024 generics accounted for an estimated 18-22% of U.S. pharmaceutical distribution volumes, helping gross margins rise ~120-180 basis points versus third-party branded sourcing.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTechnology Software and Analytics Subscriptions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMcKesson earns recurring revenue from licensing its pharmacy management and clinical SaaS platforms, which contributed an estimated $950 million in ARR (annual recurring revenue) in 2024, insulating income from drug price swings.\u003c\/p\u003e\n\u003cp\u003eManufacturers pay for access to McKesson's data analytics and market insights, generating roughly $220 million in 2024 and enhancing gross margin via high-margin services.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e$950M ARR from SaaS (2024)\u003c\/li\u003e\n\u003cli\u003e$220M from analytics (2024)\u003c\/li\u003e\n\u003cli\u003eRevenue less tied to drug price volatility\u003c\/li\u003e\n\u003cli\u003eHigh-margin, predictable income streams\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinical Trial and Provider Support Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMcKesson earns fee revenue from administrative services, clinical-trial management, and consulting to providers, helping practices boost efficiency and access high-margin research contracts; in 2024 McKesson's services segment contributed about $14.7B, with services-related gross margin ~11% driving diversified income beyond distribution.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eFees for admin, trial ops, consulting\u003c\/li\u003e\n\u003cli\u003e2024 services revenue ≈ $14.7B\u003c\/li\u003e\n\u003cli\u003eServices gross margin ≈ 11% (2024)\u003c\/li\u003e\n\u003cli\u003eEnables provider access to lucrative trials\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMcKesson diversifies: $238.5B wholesale plus growing high‑margin SaaS, services \u0026amp; specialty\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMcKesson's FY2025 revenue mix: wholesale pharma $238.5B (low 3-5% gross margin), specialty\/specialty pharmacy ~$11-13B (15-18% of FY2024; higher margins), services $14.7B (~11% GM), SaaS ARR $950M, analytics $220M; diversified mix reduces volatility and boosts high-margin services.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eStream\u003c\/th\u003e\n\u003cth\u003e2024\/25\u003c\/th\u003e\n\u003cth\u003eNotes\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eWholesale pharma\u003c\/td\u003e\n\u003ctd\u003e$238.5B (FY2025)\u003c\/td\u003e\n\u003ctd\u003e3-5% GM\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSpecialty\u003c\/td\u003e\n\u003ctd\u003e$11-13B\u003c\/td\u003e\n\u003ctd\u003e15-18% rev share; higher GM\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eServices\u003c\/td\u003e\n\u003ctd\u003e$14.7B\u003c\/td\u003e\n\u003ctd\u003e~11% GM\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSaaS\u003c\/td\u003e\n\u003ctd\u003e$950M ARR\u003c\/td\u003e\n\u003ctd\u003eRecurring\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAnalytics\u003c\/td\u003e\n\u003ctd\u003e$220M\u003c\/td\u003e\n\u003ctd\u003eHigh-margin\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e","brand":"Value Chain Analysis","offers":[{"title":"Default Title","offer_id":57357603799371,"sku":"mckesson-business-model-canvas","price":5.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1049\/6776\/6347\/files\/mckesson-canvas-business-model.webp?v=1779149745","url":"https:\/\/valuechainanalysis.com\/products\/mckesson-business-model-canvas","provider":"Value Chain Analysis","version":"1.0","type":"link"}